Andrew Rusinko

A Novel and Selective 5-HT₂ Receptor Agonist with Ocular Hypotensive Activity:  (<i>S</i>)-(+)-1-(2-Aminopropyl)-8,9-dihydropyrano[3,2-<i>e</i>]indole

Jesse A. May, Hwang‐Hsing Chen, Andrew Rusinko et al. · Journal of Medicinal Chemistry · 2003 · 43 citations · Full text

Hypertension, Pharmacotherapy, Nonhuman Primates +19

Rapid Identification of Novel Inhibitors of the Human Aquaporin‐1 Water Channel

Rajkumar V. Patil, Shouxi Xu, Alfred N. Van Hoek et al. · Chemical Biology & Drug Design · 2015 · 36 citations · Full text

Lead Compounds, Molecular Pharmacology, Medicinal Chemistry +15

2,3-Diaminopyrazines as rho kinase inhibitors

Alan J. Henderson, Mark Hadden, Cheng Guo et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 31 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Inhibitory Activity +10

In vivo optimization of 2,3-diaminopyrazine Rho Kinase inhibitors for the treatment of glaucoma

Hwang-Hsing Chen, Abdelmoulah Namil, Bryon Severns et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 19 citations · Full text

Medicine, Drug Discovery, Pharmacology +2

Chemical and biochemical studies of 2-propynylpyrrolidine derivatives. Restricted-rotation analogs of N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide (BM-5)

Eugene J. Trybulski, Richard H. Kramss, Richard M. Mangano et al. · Journal of Medicinal Chemistry · 1990 · 17 citations · Full text